Vincerx Pharma, Inc.

Q2 2024 13F Holders

Symbol
VINC
CUSIP
92731L106
Type
Equity
Class
COM NEW
Num filings
30
Total reported value, excl. options
$8.66 M
Manager Report Date Value ($000) Shares Option Type